After 1 week of therapy, the proportion of HAM-A responders was 35.5% with mexazolam and 23.3% with alprazolam; after 3 weeks of treatment, the values increased to 80.0% and 70.0%, respectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback